STOCK TITAN

Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Counterpart Health, a subsidiary of Clover Health (NASDAQ: CLOV), has successfully deployed its Counterpart Assistant technology at Duke Connected Care (DCC). The AI-powered physician enablement platform is now being used by primary care physicians across DCC's network of non-employed physicians.

The cloud-based AI platform integrates with existing electronic health record systems to provide real-time, actionable insights for improved chronic disease management and patient outcomes. DCC, part of Duke University Health System, is a physician-led accountable care organization supporting 2,200 providers and 200,000 patients.

The implementation aims to unify and optimize performance across DCC's network of community practices, particularly benefiting small rural practices that may not have access to advanced EHR systems. The technology, previously known as Clover Assistant, has demonstrated positive impacts on Clinical Quality, Medication Adherence, and management of Diabetes and Chronic Kidney Disease.

Counterpart Health, una filiale di Clover Health (NASDAQ: CLOV), ha implementato con successo la sua tecnologia Counterpart Assistant presso Duke Connected Care (DCC). La piattaforma di abilitazione per i medici, supportata dall'intelligenza artificiale, è ora utilizzata dai medici di medicina generale nella rete di medici non assunti da DCC.

La piattaforma AI basata su cloud si integra con i sistemi di cartelle cliniche elettroniche esistenti per fornire approfondimenti azionabili in tempo reale, migliorando la gestione delle malattie croniche e i risultati per i pazienti. DCC, parte del Duke University Health System, è un'organizzazione di assistenza responsabile guidata da medici che supporta 2.200 provider e 200.000 pazienti.

L'implementazione mira a unificare e ottimizzare le prestazioni nella rete di pratiche comunitarie di DCC, beneficiando in particolare le piccole pratiche rurali che potrebbero non avere accesso a sistemi EHR avanzati. La tecnologia, precedentemente conosciuta come Clover Assistant, ha dimostrato impatti positivi sulla Qualità Clinica, l'Aderenza alla Terapia e la gestione del Diabete e della Malattia Renale Cronica.

Counterpart Health, una subsidiaria de Clover Health (NASDAQ: CLOV), ha implementado con éxito su tecnología Counterpart Assistant en Duke Connected Care (DCC). La plataforma de habilitación para médicos impulsada por inteligencia artificial ahora está siendo utilizada por médicos de atención primaria en la red de médicos no empleados de DCC.

La plataforma de IA basada en la nube se integra con los sistemas existentes de registros de salud electrónicos para proporcionar información accionable en tiempo real para mejorar el manejo de enfermedades crónicas y los resultados de los pacientes. DCC, parte del sistema de salud de la Universidad de Duke, es una organización de atención responsable liderada por médicos que apoya a 2,200 proveedores y 200,000 pacientes.

La implementación tiene como objetivo unificar y optimizar el rendimiento en la red de prácticas comunitarias de DCC, beneficiando especialmente a las pequeñas prácticas rurales que pueden no tener acceso a sistemas EHR avanzados. La tecnología, anteriormente conocida como Clover Assistant, ha demostrado tener impactos positivos en la Calidad Clínica, la Adherencia a la Medicación y la gestión de la Diabetes y la Enfermedad Renal Crónica.

카운터파트 헬스(Counterpart Health)는 클로버 헬스(Clover Health)(NASDAQ: CLOV)의 자회사로, 듀크 커넥티드 케어(Duke Connected Care, DCC)에 카운터파트 어시스턴트(Counterpart Assistant) 기술을 성공적으로 배포했습니다. AI 기반의 의사 지원 플랫폼은 이제 DCC의 고용되지 않은 의사 네트워크 전역에서 1차 진료 의사들에 의해 사용되고 있습니다.

클라우드 기반 AI 플랫폼은 기존의 전자 건강 기록 시스템과 통합되어 만성 질병 관리 및 환자 결과 개선을 위한 실시간 실질적인 통찰력을 제공합니다. DCC는 듀크 대학교 건강 시스템의 일부로, 2,200명의 제공자와 200,000명의 환자를 지원하는 의사 주도 책임 의료 조직입니다.

이 구현은 DCC의 지역 사회 실습 네트워크 전반에 걸쳐 성과를 통합하고 최적화하는 것을 목표로 하며, 특히 고급 EHR 시스템에 접근할 수 없는 소규모 농촌 실습에 혜택을 줍니다. 이전에 클로버 어시스턴트(Clover Assistant)로 알려졌던 이 기술은 임상 품질, 약물 준수, 당뇨병 및 만성 신장 질환 관리에 긍정적인 영향을 미친 것으로 입증되었습니다.

Counterpart Health, une filiale de Clover Health (NASDAQ: CLOV), a déployé avec succès sa technologie Counterpart Assistant chez Duke Connected Care (DCC). La plateforme de soutien aux médecins alimentée par l'intelligence artificielle est désormais utilisée par des médecins de soins primaires au sein du réseau de médecins non employés de DCC.

La plateforme d'IA basée sur le cloud s'intègre aux systèmes de dossiers de santé électroniques existants pour fournir des informations exploitables en temps réel, améliorant ainsi la gestion des maladies chroniques et les résultats pour les patients. DCC, qui fait partie du système de santé de l'Université Duke, est une organisation de soins responsables dirigée par des médecins, soutenant 2 200 prestataires et 200 000 patients.

L'implémentation vise à unifier et à optimiser les performances au sein du réseau de pratiques communautaires de DCC, bénéficiant particulièrement aux petites pratiques rurales qui n'ont peut-être pas accès à des systèmes EHR avancés. La technologie, auparavant connue sous le nom de Clover Assistant, a montré des impacts positifs sur la qualité clinique, l'adhésion aux médicaments et la gestion du diabète et des maladies rénales chroniques.

Counterpart Health, eine Tochtergesellschaft von Clover Health (NASDAQ: CLOV), hat erfolgreich ihre Technologie Counterpart Assistant bei Duke Connected Care (DCC) implementiert. Die KI-gestützte Plattform zur Unterstützung von Ärzten wird jetzt von Allgemeinmedizinern im Netzwerk der nicht angestellten Ärzte von DCC genutzt.

Die cloudbasierte KI-Plattform wird in bestehende elektronische Gesundheitsaktensysteme integriert, um in Echtzeit umsetzbare Erkenntnisse zur Verbesserung des Managements chronischer Krankheiten und der Patientenergebnisse bereitzustellen. DCC, Teil des Duke University Health System, ist eine von Ärzten geleitete verantwortliche Gesundheitsorganisation, die 2.200 Anbieter und 200.000 Patienten unterstützt.

Das Ziel der Implementierung besteht darin, die Leistung im Netzwerk der Gemeinschaftspraktiken von DCC zu vereinheitlichen und zu optimieren, insbesondere um kleinen ländlichen Praxen zugutekommen, die möglicherweise keinen Zugang zu modernen EHR-Systemen haben. Die zuvor als Clover Assistant bekannte Technologie hat positive Auswirkungen auf die klinische Qualität, die Medikamenteneinhaltung und das Management von Diabetes und chronischen Nierenerkrankungen gezeigt.

Positive
  • Successfully deployed AI technology in a major healthcare network (Duke Connected Care)
  • Platform reaches 2,200 providers and 200,000 patients through DCC
  • Demonstrated positive impact on clinical quality and medication adherence
  • Expansion of technology beyond Clover Health's Medicare Advantage plan
Negative
  • None.

Insights

The deployment of Counterpart Assistant at Duke Connected Care represents a strategic expansion of Clover Health's AI technology beyond its core Medicare Advantage business. This partnership with a prestigious academic medical center validates the platform's capabilities and opens new revenue streams in the broader healthcare market.

The implementation across DCC's network of non-employed physicians is particularly noteworthy for three key reasons: 1) It demonstrates the platform's ability to integrate with existing EHR systems, addressing a major adoption barrier in healthcare IT, 2) It provides access to valuable data from Duke's diverse patient population, which can enhance the AI model's performance and 3) It creates a blueprint for expansion into other academic medical centers and ACOs.

The mention of successful deployment in rural practices suggests strong product-market fit in underserved areas where sophisticated health IT infrastructure is often lacking. This positions Counterpart Health to capture market share in a significantly underserved segment of healthcare providers.

This partnership marks a significant commercial milestone for CLOV's subsidiary that could materially impact future revenue streams. The successful deployment at a prestigious institution like Duke validates the technology's market potential beyond CLOV's core insurance business, potentially creating multiple new revenue channels:

1) Direct licensing revenue from healthcare providers
2) Value-based care performance improvements
3) Data monetization opportunities from broader clinical implementation

With Duke's network encompassing 2,200 providers and 200,000 patients, this deployment provides a substantial reference case for targeting other large healthcare networks. The ability to serve rural practices also expands the total addressable market significantly. While immediate financial impact may be , this positions CLOV for potential long-term growth through technology licensing and diversification beyond insurance services.

WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counterpart Assistant technology within Duke Connected Care (DCC), a recognized leader in accountable care and part of the prestigious Duke University Health System. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”).

Based in Durham, North Carolina, DCC is a physician-led accountable care organization and integral component of one of the nation’s top academic medical centers, Duke University Health System, known for its groundbreaking research, world-class medical education, and exceptional patient care. As a premier provider of healthcare services, DCC encompasses a broad network of physicians and facilities focused on value-based healthcare.

Following a successful implementation, primary care physicians across DCC’s network of non-employed physicians now have access to Counterpart Health's technology to enable advanced decision support at the point of care. Leveraging Counterpart Assistant, a cloud-based AI platform designed to seamlessly integrate with existing electronic health record (EHR) systems, clinicians receive real-time, actionable insights to help improve chronic disease management and enhance patient outcomes while maintaining their established workflows.

“DCC supports Duke Health’s strategies of delivering exceptional health outcomes and cost- effective health care in a way that fully engages patients and their loved ones with dignity and compassion,” said John Yeatts, MD, MPH, and Executive Director of DCC. “One of our goals is to unify and optimize performance across our disparate network of non-employed community practices. By leveraging cutting-edge AI technology, we are empowering our physicians with actionable insights and driving improved health outcomes.”

Conrad Wai, CEO of Counterpart Health, added, “Duke Connected Care’s reputation as a global leader in academic medicine and healthcare innovation makes this partnership especially meaningful. Our technology is purpose-built to support clinicians by delivering personalized, data-driven insights, and we’re excited to see the transformative impact it is already having across Duke’s broad and diverse network of clinicians.”

Dr. Francis Aniekwensi, a Henderson, NC-based family physician who participates in DCC’s Accountable Care Organization (ACO) stated, "I think you guys are doing a great job reducing the burden on PCPs. Especially bringing data we don't have as a small rural practice. We can't afford a fancy EHR where we might be able to get some of that automatically. The better data we have, the better job we can do of taking care of our patients.”

For more information about Counterpart Health’s AI-powered solutions and their role in transforming healthcare delivery, visit www.counterparthealth.com.

About Counterpart Health
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI powered physician enablement platform. Counterpart Health’s flagship software platform, Counterpart Assistant, was incubated by Clover Health as Clover Assistant and has helped improve plan performance and clinical outcomes for Medicare members through proprietary AI technology. Counterpart Health extends the benefits of the data-driven technology platform outside of Clover Health’s Medicare Advantage plan to a wider audience, to enable enhanced patient outcomes and reduced healthcare costs nationwide. Clover Health has published data demonstrating the technology’s impact on Clinical Quality and Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.

About Duke Connected Care
Duke Connected Care (DCC) is a community-based, physician-led network of providers that aims to improve the quality of healthcare while addressing the national challenge of rising healthcare costs. DCC is a clinically-integrated network (CIN) and Medicare Accountable Care Organization (ACO) supporting 2,200 providers and 200,000 patients in partnership with Medicare, Medicare Advantage, Medicaid, and Commercial payors.

Press Contact:
Andrew Still-Baxter
press@cloverhealth.com

Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com

DCC Contact:
Jennifer Smith
jennifer.smith730@duke.edu


FAQ

What is the impact of Counterpart Assistant deployment on CLOV's market expansion?

The deployment represents CLOV's expansion beyond Medicare Advantage, reaching 2,200 providers and 200,000 patients through Duke Connected Care, potentially opening new revenue streams.

How does Counterpart Assistant technology affect clinical outcomes for CLOV?

The technology has shown positive impacts on Clinical Quality, Medication Adherence, and improved management of Diabetes and Chronic Kidney Disease.

What is the relationship between Counterpart Health and CLOV?

Counterpart Health is a subsidiary of Clover Health (CLOV), and its Counterpart Assistant was originally incubated as Clover Assistant within Clover Health.

How does the Duke Connected Care partnership benefit CLOV's market position?

The partnership with Duke Connected Care, a prestigious healthcare organization, validates CLOV's technology and potentially opens doors for further expansion in the healthcare market.

Clover Health Investments, Corp

NASDAQ:CLOV

CLOV Rankings

CLOV Latest News

CLOV Stock Data

1.68B
388.81M
5.3%
20.18%
2.92%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
FRANKLIN